Diphenhydramine Injection, Solution
Product Images NDC 63323-664

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Diphenhydramine (NDC 63323-664). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Dip0b 0001 01)

Chemical structure diagram depicting diphenhydramine hydrochloride, showing its characteristic phenyl rings, ether linkage, and dimethylamino group.*

FDA Label Image

Logo (Dip0b 0001 02)

FDA Label Image

Diphe-label-01.jpg (Diphe Label 01)

Diphenhydramine Hydrochloride Injection, USP 50 mg per mL single dose vial from Fresenius Kabi USA, LLC. The label indicates use for intramuscular or intravenous administration, with storage instructions to protect from light and keep from freezing. The NDC is 63323-664-00.*

FDA Label Image

Diphe-label-02.jpg (Diphe Label 02)

Diphenhydramine Hydrochloride Injection, USP 50 mg per mL single-dose vials. The label indicates use for intramuscular or intravenous injection, high potency, and contains 25 x 1 mL vials. It includes storage and handling instructions and is labeled by Fresenius Kabi USA, LLC, Lake Zurich, IL.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.